Circius Pharma ApS: Financial statements 2024
CVR: 42447641
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Circius Pharma ApS (CVR 42447641) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,749,398 and a net result of DKK 0 compared with DKK -2,242,451 the year before. That is a decrease of 0.8% compared with the year before. Equity in the 2024 report amounted to DKK 3,437,320. The solvency ratio was 51.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,749,398
- Profit/Loss
- DKK 0
- Equity
- DKK 3,437,320
- Total Assets
- DKK 6,725,748
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.7 mio. | 0 | 3.4 mio. | 2 |
| 2023 | - | 2.8 mio. | -2.2 mio. | 3.4 mio. | 2 |
| 2022 | - | 2.8 mio. | -16 t. | 5.7 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Circius Pharma ApS has published its annual report for 2023. Gross profit came to DKK 2,770,374, and the net result was DKK -2,242,451.
About Circius Pharma ApS
Circius Pharma ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Erik Gustav Smith, Jan Gustav Smith and Johan Lindberg. The company is owned by Circius Pharma AB. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,858,282 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 3,437,320.